Symbicort turbuhaler is indicated in the regular treatment of asthma where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - Patients not adequaterly controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. - Or patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. NOTE: Symbicort turbuhaler 80/4.5 mcg/dose is not appropriate in patients with severe asthma.